0000950170-23-008561.txt : 20230317 0000950170-23-008561.hdr.sgml : 20230317 20230316211919 ACCESSION NUMBER: 0000950170-23-008561 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230315 ITEM INFORMATION: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review FILED AS OF DATE: 20230317 DATE AS OF CHANGE: 20230316 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CareMax, Inc. CENTRAL INDEX KEY: 0001813914 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-NURSING & PERSONAL CARE FACILITIES [8050] IRS NUMBER: 850992224 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39391 FILM NUMBER: 23740530 BUSINESS ADDRESS: STREET 1: 1000 NW 57 COURT, SUITE 400 CITY: MIAMI STATE: FL ZIP: 33126 BUSINESS PHONE: 786-360-4768 MAIL ADDRESS: STREET 1: 1000 NW 57 COURT, SUITE 400 CITY: MIAMI STATE: FL ZIP: 33126 FORMER COMPANY: FORMER CONFORMED NAME: Deerfield Healthcare Technology Acquisitions Corp. DATE OF NAME CHANGE: 20200602 8-K 1 cmax-20230315.htm 8-K 8-K
0001813914false0001813914us-gaap:CommonClassAMember2023-03-152023-03-150001813914cmax:WarrantsMember2023-03-152023-03-1500018139142023-03-152023-03-15

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 15, 2023

img231253778_0.jpg 

 

CareMax, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-39391

85-0992224

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

1000 NW 57 Court

Suite 400

 

Miami, Florida

 

33126

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 786 360-4768

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Class A common stock, par value $0.0001 per share

 

CMAX

 

The Nasdaq Stock Market LLC

Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share

 

CMAXW

 

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 


Item 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim

Review.

 

In connection with the preparation of its Annual Report on Form 10-K for the fiscal year ended December 31, 2022, CareMax, Inc., a Delaware corporation (the “Company”), reevaluated the balance sheet classification of the non-cash prepaid asset associated with the equity consideration issued to the Company’s real estate advisor in July 2021 (the “Prepaid Asset”). The Prepaid Asset was previously classified as short-term in other current assets. The Company concluded that the majority of the Prepaid Asset should instead be classified as long-term within other assets (the “Misclassification”).

 

The Misclassification related to the short-term classification of the Prepaid Asset, a non-cash asset, and has no impact on the Company’s historical reported total assets, total liabilities or total equity; revenues, expenses, or net loss; adjusted EBITDA, platform contribution, or medical expense ratio; or cash or liquidity.

 

On March 15, 2023, the Audit Committee (the “Audit Committee”) of the Board of Directors of the Company, after discussion with the Company’s management and WithumSmith+Brown, PC, the Company’s independent registered accounting firm for the year ended December 31, 2021, concluded that the Company’s (i) previously issued audited consolidated financial statements as of and for the year ended December 31, 2021 included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, (ii) previously issued unaudited consolidated financial statements as of and for the three and nine months ended September 30, 2021 included in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021, (iii) previously issued unaudited consolidated financial statements as of and for the three months ended March 31, 2022 included in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2022, (iv) previously issued unaudited consolidated financial statements as of and for the three and six months ended June 30, 2022 included in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2022 and (v) previously issued unaudited consolidated financial statements as of and for the three and nine months ended September 30, 2022 included in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022 (collectively, the “Prior Financial Statements”), the earnings release relating to the Company’s financial results as of and for the fiscal year ended December 31, 2022 (the “FY2022 Earnings Release”) and any reports, related earnings releases, investor presentations or similar communications describing the Prior Financial Statements, including the FY2022 Earnings Release, should no longer be relied upon due to the Misclassification of the Prepaid Asset.

 

As a result of the foregoing, as soon as practicable, the Company intends to amend its Annual Report on Form 10-K for the year ended December 31, 2021 and its Quarterly Reports on Form 10-Q for the quarterly periods ended September 30, 2021, March 31, 2022, June 30, 2022 and September 30, 2022 to restate its financial statements for those periods.

 

As previously disclosed, in connection with the preparation and audit of the Company’s financial statements for the year ended December 31, 2021, certain material weaknesses were identified in the Company’ internal control over financial reporting. As of the date of the filing of this Current Report on Form 8-K, management of the Company has determined that such material weaknesses had not been remediated as of December 31, 2022. As a result of the Misclassification, the Company is evaluating its disclosure controls and procedures and internal control over financial reporting. There can be no assurance that additional material weaknesses will not be identified as the Company completes its financial close process.

 

Management and the chair of the Audit Committee have discussed the matters described herein, including the restatement of the Company’s Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2022, June 30, 2022 and September 30, 2022, with the Company's current independent registered public accounting firm, PricewaterhouseCoopers LLP.

 

Forward-Looking Statements

 

This Current Report on Form 8-K may be deemed to contain forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act, and the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements include statements regarding the effects of the restatement of the Company’s past financial statements, the filing of the Company’s amended periodic reports and the Company’s evaluation of its disclosure controls and procedures and internal control over financial reporting. Words such as "anticipate," "believe," "budget," "contemplate," "continue," "could," "envision," "estimate," "expect," "guidance," "indicate," "intend," "may," "might," "plan," "possibly," "potential," "predict," "probably," "pro-forma," "project," "seek," "should," "target," or "will," or the negative or other variations thereof, and similar words or phrases or comparable terminology, are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important risks and uncertainties that could cause the Company's actual results and financial condition to differ materially from those indicated in forward-looking statements include, among others, the timing and nature of the final resolution of the accounting issues discussed in this Current Report on Form 8-K, any delay in the filing of required periodic reports with the U.S. Securities and Exchange Commission (the “SEC”), whether a restatement of financial results will be required for other accounting issues for the same or other periods in addition to the restatement currently expected by management, additional uncertainties related to accounting issues generally, adverse effects on the Company’s business as a result of the restatement process and other risks identified


in the Company's reports filed with the SEC. All information provided in this Current Report on Form 8-K is as of the date hereof, and the Company undertakes no duty to update or revise this information unless required by law.

 


 

 

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

 

Date:

March 16, 2023

By:

/s/ Kevin Wirges

 

 

 

Name: Kevin Wirges
Title: Executive Vice President, Chief Financial Officer and Treasurer

 


GRAPHIC 2 img231253778_0.jpg GRAPHIC begin 644 img231253778_0.jpg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end EX-101.SCH 3 cmax-20230315.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.PRE 4 cmax-20230315_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.DEF 5 cmax-20230315_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 cmax-20230315_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover [Abstract] Amendment Flag City Area Code Document Period End Date Document Type Entity Address, Address Line One Entity Address, Address Line Two Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, State or Province Entity Central Index Key Entity Emerging Growth Company Entity Ex Transition Period Securities Act File Number Entity Incorporation, State or Country Code Entity Registrant Name Entity Tax Identification Number Local Phone Number Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Title of 12(b) Security Security Exchange Name Soliciting Material Trading Symbol Written Communications Document Information [Table] Document Information [Line Items] Warrants. Warrants [Member] Warrants Class of Stock [Axis] Class of Stock [Domain] Common Class A [Member] XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Document And Entity Information
Mar. 15, 2023
Document Information [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date Mar. 15, 2023
Entity Registrant Name CareMax, Inc.
Entity Central Index Key 0001813914
Entity Emerging Growth Company true
Securities Act File Number 001-39391
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 85-0992224
Entity Address, Address Line One 1000 NW 57 Court
Entity Address, Address Line Two Suite 400
Entity Address, City or Town Miami
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33126
City Area Code 786
Local Phone Number 360-4768
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Ex Transition Period false
Common Class A [Member]  
Document Information [Line Items]  
Title of 12(b) Security Class A common stock, par value $0.0001 per share
Trading Symbol CMAX
Security Exchange Name NASDAQ
Warrants [Member]  
Document Information [Line Items]  
Title of 12(b) Security Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
Trading Symbol CMAXW
Security Exchange Name NASDAQ
XML 8 cmax-20230315_htm.xml IDEA: XBRL DOCUMENT 0001813914 us-gaap:CommonClassAMember 2023-03-15 2023-03-15 0001813914 cmax:WarrantsMember 2023-03-15 2023-03-15 0001813914 2023-03-15 2023-03-15 0001813914 false 8-K 2023-03-15 CareMax, Inc. DE 001-39391 85-0992224 1000 NW 57 Court Suite 400 Miami FL 33126 786 360-4768 false false false false Class A common stock, par value $0.0001 per share CMAX NASDAQ Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share CMAXW NASDAQ true false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 3 24 1 false 2 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports cmax-20230315.htm cmax-20230315.xsd cmax-20230315_def.xml cmax-20230315_lab.xml cmax-20230315_pre.xml img231253778_0.jpg http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "cmax-20230315.htm": { "axisCustom": 0, "axisStandard": 1, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 27 }, "contextCount": 3, "dts": { "definitionLink": { "local": [ "cmax-20230315_def.xml" ] }, "inline": { "local": [ "cmax-20230315.htm" ] }, "labelLink": { "local": [ "cmax-20230315_lab.xml" ] }, "presentationLink": { "local": [ "cmax-20230315_pre.xml" ] }, "schema": { "local": [ "cmax-20230315.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 31, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 1, "memberStandard": 1, "nsprefix": "cmax", "nsuri": "http://www.caremax.com/20230315", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "cmax-20230315.htm", "contextRef": "C_61b964c5-c1ad-474d-b510-73b6e2ef3f7d", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document And Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "cmax-20230315.htm", "contextRef": "C_61b964c5-c1ad-474d-b510-73b6e2ef3f7d", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "cmax_WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants.", "label": "Warrants [Member]", "terseLabel": "Warrants" } } }, "localname": "WarrantsMember", "nsuri": "http://www.caremax.com/20230315", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Securities Act File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Class A [Member]" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.caremax.com/20230315/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 15 0000950170-23-008561-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-23-008561-xbrl.zip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